Blood Pressure and Central Vascular Stiffness in Obese Children. Relationship to Metabolic Disturbances and Subclinical Cardiovascular Damage. Effect of Weight Reduction (AORTA)

March 10, 2011 updated by: Zealand University Hospital
The global epidemic of obesity in childhood continues to evolve and threaten future health and life expectancy primarily due to the increased incidence of cardiovascular disease. Obesity is strongly related to high blood pressure (hypertension) and both conditions pose a risk for target organ damage, which can follow a subject from childhood into adult life. The AORTA study will investigate central hemodynamics and organ damage in 100 obese children and adolescents in order to gain insight to the complex interplay of hypertension, obesity and subclinical damage in order to intensify more precise prevention, thereby reducing the future development of cardiovascular disease.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Holbaek, Denmark, 4300
        • Recruiting
        • Division of Cardiology, Department of Medicine, Holbaek Hospital, University of Copenhagen
        • Contact:
        • Contact:
      • Holbaek, Denmark, 4300
        • Recruiting
        • The Children's Obesity Clinic, Department of Paediatrics, Holbaek Hospital, University of Copenhagen
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age 10-18
  • BMI for age and sex above 95 percentile
  • referred for treatment at the The Children's Obesity Clinic, Department of Paediatrics, Holbaek Hospital, University of Copenhagen
  • oral and written consent by their parents

Exclusion Criteria:

  • children who can not cooperate to DEXA scanning or other procedures
  • linguistic difficulties that impair communication

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Lifestyle counseling
Treatment protocol The Children's Obesity Clinic Department of Paediatrics Holbaek Hospital, University of Copenhagen Denmark
Treatment protocol. The Children's Obesity Clinic Department of Paediatrics Holbaek Hospital, University of Copenhagen Denmark
No Intervention: Control
Healthy age and gender matched control subjects. Recruited from school visits.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Central Blood Pressure
Time Frame: one year follow up
Obtained by the SphygmoCor Device, software version 9, AtCor Medical, Australia.
one year follow up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pulse Wave velocity
Time Frame: one year follow up
Measured in meters per second.
one year follow up
Ambulatory Blood Pressure Monitoring and Clinic Blood Pressure
Time Frame: one year follow up

Measured in milimeters of mercury (mm Hg). Analysed into Blood Pressure standard deviation scores (BP SDS).

Ambulatory Blood Pressure Monitoring (ABPM) is analysed into Amulatory Arterial Stiffness Index (AASI). ASSI is 1 minus the correlation coefficient when the Systolic Blood Pressure is plottet agiant the diastolic Blood Pressure from a ABPM.

one year follow up
Heart Rate variability
Time Frame: one year follow up
one year follow up
Metabolic and Cardiovascular Blood Samples
Time Frame: one year follow up
one year follow up
Urine Albumine-Creatinine Ratio (UACR)
Time Frame: one year follow up
Microalbuminuria (MAU) defined by urine albumine-creatinine ratio (UACR) ≥ 3,5 mg/mmol (women) and 2,5 mg/mmol (men). Mean of two morning spot urine samples.
one year follow up
Echocardiography and ultrasound of aortic wall distensibility
Time Frame: one year follow up
one year follow up
Electrocardiography
Time Frame: one year follow up

Conventional 12 lead electrocardiography (ECG). Analysis of:

  • Heart rate (beats per minute)
  • P waves, QRS waves, ST segment and T waves (durations: miliseconds, amplitude: milimeters/Voltage)
  • Intervals: PQ, PR, QRS, ST, T waves (miliseconds)
  • Configuration of the T wave.
one year follow up
Dual energy X-ray absorptionmetry (DEXA scan)
Time Frame: one year follow up

A full body DEXA scan gives precise knowlegde of the body fat mass and fat free mass. Fat mass can be converted into fat mass index and fat free mass can be converted into fat free mass index, besides BMI standard deviation score (BMI SDS).

A DEXA scan also gives information on bone mineral density (BMD), a parameter of bone status, and regional estimates: truncus, abdomen, thorax, arms and legs.

one year follow up
Anthropometric measures
Time Frame: one year follow up
Height, Waist, Weight, BMI (weight/height²)
one year follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kristian Hvidt, MD, Division of Cardiology, Department of Medicine, Holbaek Hospital, University of Copenhagen, Denmark
  • Study Chair: Hans Ibsen, DMSc, MD, Division of Cardiology, Department of Medicine, Holbaek Hospital, University of Copenhagen
  • Study Director: Jens-Christian Holm, PhD, MD, The Children's Obesity Clinic, Department of Paediatrics, Holbaek Hospital, University of Copenhagen
  • Study Director: Michael Hecht Olsen, DMSc, PhD, MD, Division of Cardiology, Department of Medicine, Glostrup Hospital, University of Copenhagen

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2011

Primary Completion (Anticipated)

June 1, 2013

Study Completion (Anticipated)

December 1, 2013

Study Registration Dates

First Submitted

February 28, 2011

First Submitted That Met QC Criteria

March 3, 2011

First Posted (Estimate)

March 7, 2011

Study Record Updates

Last Update Posted (Estimate)

March 11, 2011

Last Update Submitted That Met QC Criteria

March 10, 2011

Last Verified

March 1, 2011

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adolescent

Clinical Trials on Lifestyle intervention

Subscribe